

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 6.07183760 |
| 2 | DNA deamination (GO:0045006) | 5.25225271 |
| 3 | doxorubicin metabolic process (GO:0044598) | 5.23614908 |
| 4 | daunorubicin metabolic process (GO:0044597) | 5.23614908 |
| 5 | polyketide metabolic process (GO:0030638) | 5.23614908 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 4.79978610 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 4.79978610 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.69047326 |
| 9 | protein targeting to ER (GO:0045047) | 4.60359363 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.60240647 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 4.50738868 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.41737527 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.36040809 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.02215837 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.94457663 |
| 16 | proteasome assembly (GO:0043248) | 3.88890447 |
| 17 | viral transcription (GO:0019083) | 3.72952457 |
| 18 | protein retention in ER lumen (GO:0006621) | 3.66249366 |
| 19 | translational termination (GO:0006415) | 3.62661665 |
| 20 | GDP-mannose metabolic process (GO:0019673) | 3.52833546 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.52826906 |
| 22 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.51887381 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.49917753 |
| 24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.48362265 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.46460437 |
| 26 | mitotic nuclear envelope reassembly (GO:0007084) | 3.44423392 |
| 27 | nuclear envelope reassembly (GO:0031468) | 3.44423392 |
| 28 | translation (GO:0006412) | 3.43765321 |
| 29 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.42065940 |
| 30 | pinocytosis (GO:0006907) | 3.39637157 |
| 31 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.33284691 |
| 32 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.32302103 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.30957127 |
| 34 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.28553302 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 3.28553302 |
| 36 | translational elongation (GO:0006414) | 3.27767946 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.25808286 |
| 38 | ribosomal small subunit biogenesis (GO:0042274) | 3.25715499 |
| 39 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.16422994 |
| 40 | aldehyde catabolic process (GO:0046185) | 3.16229996 |
| 41 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.15973624 |
| 42 | lipopolysaccharide metabolic process (GO:0008653) | 3.13649201 |
| 43 | protein complex biogenesis (GO:0070271) | 3.12919833 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.11927154 |
| 45 | mannosylation (GO:0097502) | 3.09220335 |
| 46 | extracellular fibril organization (GO:0043206) | 3.07395604 |
| 47 | proline biosynthetic process (GO:0006561) | 3.06103840 |
| 48 | regulation of mitochondrial translation (GO:0070129) | 3.05894566 |
| 49 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.02199654 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.99890176 |
| 51 | UV protection (GO:0009650) | 2.99278204 |
| 52 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99218841 |
| 53 | membrane raft organization (GO:0031579) | 2.98996086 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.98923738 |
| 55 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.97386188 |
| 56 | NADH dehydrogenase complex assembly (GO:0010257) | 2.97386188 |
| 57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.97386188 |
| 58 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.97221347 |
| 59 | protein targeting to membrane (GO:0006612) | 2.95739628 |
| 60 | skin morphogenesis (GO:0043589) | 2.94113691 |
| 61 | viral life cycle (GO:0019058) | 2.92405124 |
| 62 | L-methionine salvage (GO:0071267) | 2.91628392 |
| 63 | L-methionine biosynthetic process (GO:0071265) | 2.91628392 |
| 64 | amino acid salvage (GO:0043102) | 2.91628392 |
| 65 | nucleotide transmembrane transport (GO:1901679) | 2.89147134 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88906607 |
| 67 | establishment of viral latency (GO:0019043) | 2.87118191 |
| 68 | COPII vesicle coating (GO:0048208) | 2.86454556 |
| 69 | protein deneddylation (GO:0000338) | 2.86012519 |
| 70 | fibril organization (GO:0097435) | 2.85497743 |
| 71 | type B pancreatic cell proliferation (GO:0044342) | 2.83497075 |
| 72 | hyaluronan catabolic process (GO:0030214) | 2.82748422 |
| 73 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.82406645 |
| 74 | peptidyl-histidine modification (GO:0018202) | 2.81834590 |
| 75 | barbed-end actin filament capping (GO:0051016) | 2.80698595 |
| 76 | translational initiation (GO:0006413) | 2.79987495 |
| 77 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.79826740 |
| 78 | virion attachment to host cell (GO:0019062) | 2.79780847 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 2.79780847 |
| 80 | cullin deneddylation (GO:0010388) | 2.79319807 |
| 81 | cytochrome complex assembly (GO:0017004) | 2.79271485 |
| 82 | maturation of SSU-rRNA (GO:0030490) | 2.78378425 |
| 83 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.78240880 |
| 84 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.78240880 |
| 85 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.76795498 |
| 86 | negative regulation of ligase activity (GO:0051352) | 2.76795498 |
| 87 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.76370067 |
| 88 | regulation of metalloenzyme activity (GO:0048552) | 2.76189335 |
| 89 | pseudouridine synthesis (GO:0001522) | 2.75059884 |
| 90 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.73950059 |
| 91 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.73397810 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.72596766 |
| 93 | adhesion of symbiont to host (GO:0044406) | 2.72474387 |
| 94 | ribosomal large subunit biogenesis (GO:0042273) | 2.72144347 |
| 95 | tRNA methylation (GO:0030488) | 2.71199338 |
| 96 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.71189560 |
| 97 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70968003 |
| 98 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.70818427 |
| 99 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.70805205 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.70805205 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.70657439 |
| 102 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69441049 |
| 103 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69441049 |
| 104 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69441049 |
| 105 | DNA strand elongation (GO:0022616) | 2.69158394 |
| 106 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.68129304 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.68129304 |
| 108 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.67411031 |
| 109 | L-phenylalanine metabolic process (GO:0006558) | 2.67411031 |
| 110 | peptidyl-asparagine modification (GO:0018196) | 2.66588696 |
| 111 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.66420154 |
| 112 | cellular protein complex disassembly (GO:0043624) | 2.65619107 |
| 113 | eosinophil chemotaxis (GO:0048245) | 2.65614017 |
| 114 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.65069723 |
| 115 | metallo-sulfur cluster assembly (GO:0031163) | 2.62802348 |
| 116 | iron-sulfur cluster assembly (GO:0016226) | 2.62802348 |
| 117 | GTP biosynthetic process (GO:0006183) | 2.62274045 |
| 118 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.60999523 |
| 119 | protein autoprocessing (GO:0016540) | 2.60918979 |
| 120 | respiratory electron transport chain (GO:0022904) | 2.60808650 |
| 121 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60232983 |
| 122 | telomere maintenance via recombination (GO:0000722) | 2.60125984 |
| 123 | heme biosynthetic process (GO:0006783) | 2.59838659 |
| 124 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.58096945 |
| 125 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56760225 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56760225 |
| 127 | pyrimidine nucleoside salvage (GO:0043097) | 2.56581933 |
| 128 | pyrimidine-containing compound salvage (GO:0008655) | 2.56581933 |
| 129 | negative regulation of mitochondrion organization (GO:0010823) | 2.56064349 |
| 130 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.55444134 |
| 131 | electron transport chain (GO:0022900) | 2.55369279 |
| 132 | L-serine metabolic process (GO:0006563) | 2.54130555 |
| 133 | regulation of cellular amine metabolic process (GO:0033238) | 2.53778924 |
| 134 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.53463066 |
| 135 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.52633522 |
| 136 | positive regulation of ligase activity (GO:0051351) | 2.51565869 |
| 137 | pentose-phosphate shunt (GO:0006098) | 2.50152007 |
| 138 | protein localization to endosome (GO:0036010) | 2.48218542 |
| 139 | positive regulation of cell cycle arrest (GO:0071158) | 2.48063627 |
| 140 | cell redox homeostasis (GO:0045454) | 2.46732806 |
| 141 | peptidyl-proline hydroxylation (GO:0019511) | 2.46334275 |
| 142 | chaperone-mediated protein transport (GO:0072321) | 2.45992919 |
| 143 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.45815384 |
| 144 | apoptotic cell clearance (GO:0043277) | 2.45464012 |
| 145 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.45373634 |
| 146 | 4-hydroxyproline metabolic process (GO:0019471) | 2.42397079 |
| 147 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.41564336 |
| 148 | protein hydroxylation (GO:0018126) | 2.40599940 |
| 149 | glycosphingolipid catabolic process (GO:0046479) | 2.39707767 |
| 150 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.39559115 |
| 151 | positive regulation of nuclease activity (GO:0032075) | 2.38078202 |
| 152 | glucose catabolic process (GO:0006007) | 2.36599538 |
| 153 | response to interferon-beta (GO:0035456) | 2.35827934 |
| 154 | eosinophil migration (GO:0072677) | 2.35038298 |
| 155 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.33189791 |
| 156 | macrophage chemotaxis (GO:0048246) | 2.30717722 |
| 157 | regulation of mitochondrial membrane potential (GO:0051881) | 2.30467980 |
| 158 | regulation of monocyte chemotaxis (GO:0090025) | 2.29838734 |
| 159 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.28771048 |
| 160 | glial cell migration (GO:0008347) | 2.28446276 |
| 161 | cellular response to unfolded protein (GO:0034620) | 2.27289884 |
| 162 | cellular copper ion homeostasis (GO:0006878) | 2.26920640 |
| 163 | pentose metabolic process (GO:0019321) | 2.25546910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.43821268 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.10973510 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.02943344 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.86687038 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.69151599 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.55480438 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.54957905 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.54599250 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.16323811 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.10153153 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.88524858 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87195789 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69775014 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59439806 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.57505321 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.56516932 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56322322 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.55930396 |
| 19 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.47305076 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.41974430 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.40939236 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.36593513 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.32769098 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.32396533 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30405941 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29397339 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.28179748 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.22438930 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20197107 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18075859 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08754330 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.06625966 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05253029 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04825040 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03010971 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.98254997 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97099802 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.92688917 |
| 39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.91866600 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.88095068 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87261642 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86126703 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.86090535 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.82275269 |
| 45 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.82211867 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81889729 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.74774493 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74472898 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73832886 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72153975 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71573416 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70606976 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70295023 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65110854 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62319353 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61343632 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59787432 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57717766 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57711327 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48951247 |
| 61 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.47461748 |
| 62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46995992 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45549892 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.45224825 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44485276 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43215059 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42767151 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41589055 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41412164 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39488740 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39430317 |
| 72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37292299 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37157769 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37005266 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33798855 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33430249 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32317060 |
| 78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32200657 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31902948 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28957045 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28946038 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28830320 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27784631 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27759698 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23939357 |
| 86 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23680352 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22178405 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20603726 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20476662 |
| 90 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.20368587 |
| 91 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19568113 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15808894 |
| 93 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15397590 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14521149 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13530006 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13122859 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11428977 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10826299 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10560253 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08991536 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08792242 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07138676 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06900936 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05796958 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05121623 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04458545 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03976025 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03775128 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03057213 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02826262 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02345280 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01895941 |
| 113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00786542 |
| 114 | P68_20966046_ChIP-Seq_HELA_Human | 1.00278402 |
| 115 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00122128 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99822110 |
| 117 | MYC_22102868_ChIP-Seq_BL_Human | 0.99679379 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99641827 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98940296 |
| 120 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98864369 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98839050 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98808566 |
| 123 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98798719 |
| 124 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98436896 |
| 125 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98104997 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97809691 |
| 127 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97763483 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97514049 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97354131 |
| 130 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96180941 |
| 131 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96050525 |
| 132 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95497980 |
| 133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90634144 |
| 134 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89798345 |
| 135 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89243497 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84078084 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83436098 |
| 138 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83019803 |
| 139 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.82780930 |
| 140 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81102147 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81011357 |
| 142 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.80686843 |
| 143 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80520943 |
| 144 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80176050 |
| 145 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.79867475 |
| 146 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79365584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.51825287 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.26910417 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.71545412 |
| 4 | MP0009379_abnormal_foot_pigmentation | 2.62816653 |
| 5 | MP0005365_abnormal_bile_salt | 2.61309629 |
| 6 | MP0006054_spinal_hemorrhage | 2.57468080 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.54789134 |
| 8 | MP0003186_abnormal_redox_activity | 2.53637780 |
| 9 | MP0005220_abnormal_exocrine_pancreas | 2.51517599 |
| 10 | MP0005083_abnormal_biliary_tract | 2.45765535 |
| 11 | MP0004272_abnormal_basement_membrane | 2.42433808 |
| 12 | MP0003195_calcinosis | 2.38487228 |
| 13 | MP0003279_aneurysm | 2.35009886 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.25910251 |
| 15 | MP0009697_abnormal_copulation | 2.24325006 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.17739459 |
| 17 | MP0001764_abnormal_homeostasis | 2.09850940 |
| 18 | MP0005451_abnormal_body_composition | 2.04625313 |
| 19 | MP0000343_altered_response_to | 2.04139404 |
| 20 | MP0006082_CNS_inflammation | 1.99244194 |
| 21 | MP0008004_abnormal_stomach_pH | 1.99081056 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.98948487 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.92938692 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.84661163 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.83619197 |
| 26 | MP0005165_increased_susceptibility_to | 1.81033004 |
| 27 | MP0005360_urolithiasis | 1.79919504 |
| 28 | MP0001958_emphysema | 1.78850694 |
| 29 | MP0003075_altered_response_to | 1.77777630 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.74798848 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.70575078 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 1.67876353 |
| 33 | MP0003436_decreased_susceptibility_to | 1.65206995 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.61439413 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.59381448 |
| 36 | MP0003724_increased_susceptibility_to | 1.59355032 |
| 37 | MP0002132_abnormal_respiratory_system | 1.59108989 |
| 38 | MP0002060_abnormal_skin_morphology | 1.58233341 |
| 39 | MP0002693_abnormal_pancreas_physiology | 1.56302997 |
| 40 | MP0009785_altered_susceptibility_to | 1.52779566 |
| 41 | MP0001243_abnormal_dermal_layer | 1.46786803 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.46769590 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.46672652 |
| 44 | MP0008260_abnormal_autophagy | 1.46158869 |
| 45 | MP0005408_hypopigmentation | 1.45956765 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.45747499 |
| 47 | MP0005023_abnormal_wound_healing | 1.45574397 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.45113154 |
| 49 | MP0000490_abnormal_crypts_of | 1.43891744 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.43752988 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.43413318 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.42541038 |
| 53 | MP0003868_abnormal_feces_composition | 1.40480357 |
| 54 | MP0005332_abnormal_amino_acid | 1.39070219 |
| 55 | MP0000604_amyloidosis | 1.38540315 |
| 56 | MP0003448_altered_tumor_morphology | 1.37741059 |
| 57 | MP0001944_abnormal_pancreas_morphology | 1.36389677 |
| 58 | MP0004858_abnormal_nervous_system | 1.35958780 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.35414095 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32319917 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.30569569 |
| 62 | MP0001542_abnormal_bone_strength | 1.24472153 |
| 63 | MP0005275_abnormal_skin_tensile | 1.22411272 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.22405824 |
| 65 | MP0004043_abnormal_pH_regulation | 1.21216226 |
| 66 | MP0000681_abnormal_thyroid_gland | 1.21128461 |
| 67 | MP0002419_abnormal_innate_immunity | 1.20684179 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.20238782 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.20123359 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.19774717 |
| 71 | MP0008469_abnormal_protein_level | 1.19537065 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.18336943 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.17209489 |
| 74 | MP0009764_decreased_sensitivity_to | 1.16664723 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.14842297 |
| 76 | MP0005025_abnormal_response_to | 1.13955952 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.13524451 |
| 78 | MP0002938_white_spotting | 1.12590745 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.12520629 |
| 80 | MP0003329_amyloid_beta_deposits | 1.10785562 |
| 81 | MP0000613_abnormal_salivary_gland | 1.07893622 |
| 82 | MP0003252_abnormal_bile_duct | 1.06314930 |
| 83 | MP0008058_abnormal_DNA_repair | 1.06078704 |
| 84 | MP0003786_premature_aging | 1.04729607 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.04038006 |
| 86 | MP0000858_altered_metastatic_potential | 1.04024211 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.03773377 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.03581762 |
| 89 | MP0005164_abnormal_response_to | 1.03511834 |
| 90 | MP0000685_abnormal_immune_system | 1.02614408 |
| 91 | MP0009840_abnormal_foam_cell | 1.02466710 |
| 92 | MP0005166_decreased_susceptibility_to | 1.00974935 |
| 93 | MP0002163_abnormal_gland_morphology | 1.00039867 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.99653629 |
| 95 | MP0004947_skin_inflammation | 0.99572505 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.99335509 |
| 97 | MP0003303_peritoneal_inflammation | 0.98844306 |
| 98 | MP0002933_joint_inflammation | 0.98761701 |
| 99 | MP0005508_abnormal_skeleton_morphology | 0.98499410 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.97923628 |
| 101 | MP0008932_abnormal_embryonic_tissue | 0.96578961 |
| 102 | MP0005671_abnormal_response_to | 0.96466564 |
| 103 | MP0004510_myositis | 0.96058432 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.93317728 |
| 105 | MP0002723_abnormal_immune_serum | 0.90590471 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.90422131 |
| 107 | MP0003795_abnormal_bone_structure | 0.90412617 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.90311306 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.89527045 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.88873787 |
| 111 | MP0001849_ear_inflammation | 0.88064252 |
| 112 | MP0005387_immune_system_phenotype | 0.87880574 |
| 113 | MP0001790_abnormal_immune_system | 0.87880574 |
| 114 | MP0009763_increased_sensitivity_to | 0.87591647 |
| 115 | MP0005000_abnormal_immune_tolerance | 0.87426785 |
| 116 | MP0010329_abnormal_lipoprotein_level | 0.86439733 |
| 117 | MP0000609_abnormal_liver_physiology | 0.85704386 |
| 118 | MP0005330_cardiomyopathy | 0.85542513 |
| 119 | MP0000358_abnormal_cell_content/ | 0.84775257 |
| 120 | MP0000751_myopathy | 0.84087319 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.84055708 |
| 122 | MP0009278_abnormal_bone_marrow | 0.83026329 |
| 123 | MP0001756_abnormal_urination | 0.82809409 |
| 124 | MP0001881_abnormal_mammary_gland | 0.82580160 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.82138505 |
| 126 | MP0002420_abnormal_adaptive_immunity | 0.81739857 |
| 127 | MP0003091_abnormal_cell_migration | 0.81503970 |
| 128 | MP0004147_increased_porphyrin_level | 0.81409940 |
| 129 | MP0005390_skeleton_phenotype | 0.81373301 |
| 130 | MP0001819_abnormal_immune_cell | 0.81234144 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.81099042 |
| 132 | MP0005377_hearing/vestibular/ear_phenot | 0.80441602 |
| 133 | MP0003878_abnormal_ear_physiology | 0.80441602 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.80106392 |
| 135 | MP0000598_abnormal_liver_morphology | 0.79451518 |
| 136 | MP0003011_delayed_dark_adaptation | 0.79090488 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.79082183 |
| 138 | MP0001727_abnormal_embryo_implantation | 0.78975614 |
| 139 | MP0003866_abnormal_defecation | 0.78802947 |
| 140 | MP0003191_abnormal_cellular_cholesterol | 0.77678886 |
| 141 | MP0010030_abnormal_orbit_morphology | 0.77644396 |
| 142 | MP0005376_homeostasis/metabolism_phenot | 0.77471333 |
| 143 | MP0001853_heart_inflammation | 0.77185916 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.76490925 |
| 145 | MP0003077_abnormal_cell_cycle | 0.75502830 |
| 146 | MP0003453_abnormal_keratinocyte_physiol | 0.74193402 |
| 147 | MP0010155_abnormal_intestine_physiology | 0.73830347 |
| 148 | MP0002118_abnormal_lipid_homeostasis | 0.73825811 |
| 149 | MP0001664_abnormal_digestion | 0.73701630 |
| 150 | MP0002405_respiratory_system_inflammati | 0.72810652 |
| 151 | MP0001663_abnormal_digestive_system | 0.72190201 |
| 152 | MP0005197_abnormal_uvea_morphology | 0.72097702 |
| 153 | MP0009642_abnormal_blood_homeostasis | 0.71204623 |
| 154 | MP0004381_abnormal_hair_follicle | 0.70786746 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70732082 |
| 156 | MP0001661_extended_life_span | 0.70511324 |
| 157 | MP0001545_abnormal_hematopoietic_system | 0.70201164 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.70201164 |
| 159 | MP0000003_abnormal_adipose_tissue | 0.68991925 |
| 160 | MP0002429_abnormal_blood_cell | 0.68922764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.51603187 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.82896089 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.82896089 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.82896089 |
| 5 | Type I transferrin isoform profile (HP:0003642) | 4.08655959 |
| 6 | Hepatic necrosis (HP:0002605) | 3.95791569 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.92287138 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.69649054 |
| 9 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.69142033 |
| 10 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.69142033 |
| 11 | Abnormal protein glycosylation (HP:0012346) | 3.69142033 |
| 12 | Abnormal glycosylation (HP:0012345) | 3.69142033 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.68833502 |
| 14 | Reduced antithrombin III activity (HP:0001976) | 3.56302699 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.51426503 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.49360604 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.45560663 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.41250104 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.30307764 |
| 20 | Aplastic anemia (HP:0001915) | 3.29880114 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.27970943 |
| 22 | Acute encephalopathy (HP:0006846) | 3.25946966 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.25834586 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.23872106 |
| 25 | Increased CSF lactate (HP:0002490) | 3.21540720 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.14528046 |
| 27 | Generalized aminoaciduria (HP:0002909) | 3.05658895 |
| 28 | Hypoglycemic seizures (HP:0002173) | 3.01359821 |
| 29 | Reticulocytopenia (HP:0001896) | 3.00880915 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.99681647 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 2.95948576 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.95704360 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.95704360 |
| 34 | Symptomatic seizures (HP:0011145) | 2.85906288 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82982139 |
| 36 | Increased serum lactate (HP:0002151) | 2.76963063 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.73678389 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.71160838 |
| 39 | Exertional dyspnea (HP:0002875) | 2.70905776 |
| 40 | Thrombocytosis (HP:0001894) | 2.70445634 |
| 41 | Achilles tendon contracture (HP:0001771) | 2.69916813 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64395148 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64395148 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64395148 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.58743187 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.56841448 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.55909072 |
| 48 | Prolonged neonatal jaundice (HP:0006579) | 2.55529093 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.55482898 |
| 50 | Cholecystitis (HP:0001082) | 2.55482898 |
| 51 | Beaking of vertebral bodies (HP:0004568) | 2.54464006 |
| 52 | Opisthotonus (HP:0002179) | 2.50464138 |
| 53 | Atrophic scars (HP:0001075) | 2.49245682 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.48704312 |
| 55 | Glycosuria (HP:0003076) | 2.48704312 |
| 56 | Abnormality of dentin (HP:0010299) | 2.48575895 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.47723235 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47723235 |
| 59 | Cerebral edema (HP:0002181) | 2.46796195 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.45256794 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.45256794 |
| 62 | Elbow flexion contracture (HP:0002987) | 2.44977400 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 2.44904414 |
| 64 | Lactic acidosis (HP:0003128) | 2.43741901 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41127876 |
| 66 | Ankle contracture (HP:0006466) | 2.38748175 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37725058 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.37725058 |
| 69 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.37179004 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.36439131 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.35676501 |
| 72 | Joint stiffness (HP:0001387) | 2.35492794 |
| 73 | Nonimmune hydrops fetalis (HP:0001790) | 2.34988779 |
| 74 | Microvesicular hepatic steatosis (HP:0001414) | 2.34444544 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.32906803 |
| 76 | Cervical subluxation (HP:0003308) | 2.32344968 |
| 77 | Hand muscle atrophy (HP:0009130) | 2.31472402 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.31323026 |
| 79 | 11 pairs of ribs (HP:0000878) | 2.30708287 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 2.28567693 |
| 81 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28567693 |
| 82 | Parakeratosis (HP:0001036) | 2.28416477 |
| 83 | Respiratory failure (HP:0002878) | 2.26579321 |
| 84 | Blue sclerae (HP:0000592) | 2.26560200 |
| 85 | Poor head control (HP:0002421) | 2.24687729 |
| 86 | Abnormality of renal resorption (HP:0011038) | 2.23673043 |
| 87 | Macrocytic anemia (HP:0001972) | 2.19991403 |
| 88 | Orthostatic hypotension (HP:0001278) | 2.19826446 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 2.19709482 |
| 90 | Hypobetalipoproteinemia (HP:0003563) | 2.17371662 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17017720 |
| 92 | Follicular hyperkeratosis (HP:0007502) | 2.16944266 |
| 93 | Exercise intolerance (HP:0003546) | 2.16220913 |
| 94 | Abnormality of the common coagulation pathway (HP:0010990) | 2.15434358 |
| 95 | Nuclear cataract (HP:0100018) | 2.14024118 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.12997848 |
| 97 | Loss of speech (HP:0002371) | 2.12837397 |
| 98 | Wormian bones (HP:0002645) | 2.12676907 |
| 99 | Generalized amyotrophy (HP:0003700) | 2.12064276 |
| 100 | Spinal rigidity (HP:0003306) | 2.10511819 |
| 101 | Distal lower limb muscle weakness (HP:0009053) | 2.09836492 |
| 102 | Hyperphosphaturia (HP:0003109) | 2.09387493 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.09261161 |
| 104 | Hypertensive crisis (HP:0100735) | 2.08896709 |
| 105 | Fragile skin (HP:0001030) | 2.08258711 |
| 106 | Conjugated hyperbilirubinemia (HP:0002908) | 2.07740395 |
| 107 | Abnormal trabecular bone morphology (HP:0100671) | 2.07291042 |
| 108 | Abnormality of macrophages (HP:0004311) | 2.06335947 |
| 109 | Amyloidosis (HP:0011034) | 2.04976400 |
| 110 | Steatorrhea (HP:0002570) | 2.03755130 |
| 111 | Hypokinesia (HP:0002375) | 2.02002265 |
| 112 | Axonal loss (HP:0003447) | 2.01972559 |
| 113 | Intrahepatic cholestasis (HP:0001406) | 2.01488834 |
| 114 | Abnormality of dental color (HP:0011073) | 2.00601091 |
| 115 | Trismus (HP:0000211) | 2.00390563 |
| 116 | Pancytopenia (HP:0001876) | 1.99432723 |
| 117 | Fat malabsorption (HP:0002630) | 1.99256654 |
| 118 | Pallor (HP:0000980) | 1.99209015 |
| 119 | Increased serum ferritin (HP:0003281) | 1.97564033 |
| 120 | Lethargy (HP:0001254) | 1.96992545 |
| 121 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96277602 |
| 122 | Short nail (HP:0001799) | 1.96192076 |
| 123 | CNS demyelination (HP:0007305) | 1.94874948 |
| 124 | Dysostosis multiplex (HP:0000943) | 1.94505348 |
| 125 | Bladder diverticulum (HP:0000015) | 1.92736210 |
| 126 | Absent eyelashes (HP:0000561) | 1.92496429 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91442469 |
| 128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90959139 |
| 129 | Entropion (HP:0000621) | 1.90937908 |
| 130 | Respiratory difficulties (HP:0002880) | 1.90650713 |
| 131 | Biconcave vertebral bodies (HP:0004586) | 1.89377931 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.89070471 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.87506260 |
| 134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86759698 |
| 135 | Hyperbilirubinemia (HP:0002904) | 1.86163971 |
| 136 | Aortic dissection (HP:0002647) | 1.85921959 |
| 137 | Glucose intolerance (HP:0000833) | 1.85912527 |
| 138 | Testicular atrophy (HP:0000029) | 1.84732307 |
| 139 | Purpura (HP:0000979) | 1.84248969 |
| 140 | Ketosis (HP:0001946) | 1.83344489 |
| 141 | Esophageal neoplasm (HP:0100751) | 1.83044593 |
| 142 | Neoplasm of head and neck (HP:0012288) | 1.83044593 |
| 143 | Late onset (HP:0003584) | 1.82523198 |
| 144 | Methylmalonic aciduria (HP:0012120) | 1.81590945 |
| 145 | Oral leukoplakia (HP:0002745) | 1.81290628 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80373484 |
| 147 | Abnormality of the acetabulum (HP:0003170) | 1.78943291 |
| 148 | Petechiae (HP:0000967) | 1.78818628 |
| 149 | Irregular epiphyses (HP:0010582) | 1.78774203 |
| 150 | Cerebral hypomyelination (HP:0006808) | 1.77615353 |
| 151 | Microretrognathia (HP:0000308) | 1.77606107 |
| 152 | Irregular vertebral endplates (HP:0003301) | 1.77362737 |
| 153 | Increased serum pyruvate (HP:0003542) | 1.76949855 |
| 154 | Abnormal pupillary function (HP:0007686) | 1.76744061 |
| 155 | Myocardial infarction (HP:0001658) | 1.76718092 |
| 156 | Spondylolisthesis (HP:0003302) | 1.76402250 |
| 157 | Redundant skin (HP:0001582) | 1.75902526 |
| 158 | Premature skin wrinkling (HP:0100678) | 1.74774055 |
| 159 | Abnormality of glycolysis (HP:0004366) | 1.74547567 |
| 160 | Increased connective tissue (HP:0009025) | 1.73510503 |
| 161 | Peritonitis (HP:0002586) | 1.71325908 |
| 162 | Soft skin (HP:0000977) | 1.71238543 |
| 163 | Sparse eyelashes (HP:0000653) | 1.70504146 |
| 164 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.70503896 |
| 165 | Ketoacidosis (HP:0001993) | 1.69185518 |
| 166 | Megaloblastic anemia (HP:0001889) | 1.69102336 |
| 167 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68962794 |
| 168 | Fasciculations (HP:0002380) | 1.68903535 |
| 169 | Abnormal tarsal ossification (HP:0008369) | 1.66362802 |
| 170 | Rough bone trabeculation (HP:0100670) | 1.65702437 |
| 171 | Abnormal urine phosphate concentration (HP:0012599) | 1.64610054 |
| 172 | Secondary amenorrhea (HP:0000869) | 1.63538501 |
| 173 | Abnormality of T cell physiology (HP:0011840) | 1.61419072 |
| 174 | Epiphyseal stippling (HP:0010655) | 1.61364407 |
| 175 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.61317224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.96789712 |
| 2 | STK16 | 3.77033181 |
| 3 | EIF2AK3 | 3.38005112 |
| 4 | VRK2 | 3.23838905 |
| 5 | BCKDK | 3.10398011 |
| 6 | BUB1 | 2.83642639 |
| 7 | ERN1 | 2.72691197 |
| 8 | EIF2AK1 | 2.67308393 |
| 9 | PIM2 | 2.66214012 |
| 10 | TAOK3 | 2.32856631 |
| 11 | TESK2 | 2.31044566 |
| 12 | IRAK3 | 2.21317021 |
| 13 | TLK1 | 2.18938304 |
| 14 | PASK | 2.08787528 |
| 15 | KDR | 1.94143552 |
| 16 | VRK1 | 1.91971374 |
| 17 | IRAK4 | 1.87120923 |
| 18 | FLT3 | 1.85892911 |
| 19 | WEE1 | 1.79942217 |
| 20 | PIK3CG | 1.77681809 |
| 21 | MST1R | 1.72233567 |
| 22 | TESK1 | 1.65991271 |
| 23 | BRSK2 | 1.60318854 |
| 24 | MAP3K3 | 1.51703373 |
| 25 | SIK3 | 1.47228425 |
| 26 | MOS | 1.46376177 |
| 27 | TEC | 1.40971048 |
| 28 | BMPR1B | 1.38565397 |
| 29 | SMG1 | 1.38206556 |
| 30 | MAPK15 | 1.37930517 |
| 31 | TGFBR2 | 1.33474187 |
| 32 | PBK | 1.31847391 |
| 33 | CDK8 | 1.26883609 |
| 34 | MAP3K11 | 1.25487781 |
| 35 | MAPKAPK3 | 1.25176489 |
| 36 | RPS6KA4 | 1.22743642 |
| 37 | LMTK2 | 1.20197480 |
| 38 | NME1 | 1.16053039 |
| 39 | SIK1 | 1.15599533 |
| 40 | SCYL2 | 1.14845023 |
| 41 | TNIK | 1.12394361 |
| 42 | MAP3K12 | 1.12266987 |
| 43 | EPHA2 | 1.10507033 |
| 44 | BLK | 1.08046215 |
| 45 | PTK2 | 1.05354145 |
| 46 | SRPK1 | 1.02911676 |
| 47 | TBK1 | 1.01909631 |
| 48 | GRK7 | 1.01881414 |
| 49 | BRAF | 1.00356009 |
| 50 | DAPK1 | 0.98580419 |
| 51 | KIT | 0.98060754 |
| 52 | ACVR1B | 0.97960843 |
| 53 | ZAP70 | 0.97061072 |
| 54 | EPHB2 | 0.93703086 |
| 55 | DDR2 | 0.93333512 |
| 56 | DAPK3 | 0.92393438 |
| 57 | ABL2 | 0.92371141 |
| 58 | LIMK1 | 0.89961613 |
| 59 | CAMKK2 | 0.89907546 |
| 60 | MAP2K2 | 0.88940310 |
| 61 | TYK2 | 0.88543954 |
| 62 | BTK | 0.87678351 |
| 63 | FRK | 0.85413523 |
| 64 | EIF2AK2 | 0.84611912 |
| 65 | STK10 | 0.84348236 |
| 66 | PLK4 | 0.79608997 |
| 67 | TRIB3 | 0.79339622 |
| 68 | NEK1 | 0.77908067 |
| 69 | ZAK | 0.76696817 |
| 70 | CDK7 | 0.76218933 |
| 71 | NEK9 | 0.75879414 |
| 72 | NTRK1 | 0.75409447 |
| 73 | TGFBR1 | 0.73943324 |
| 74 | PDK2 | 0.73316530 |
| 75 | INSRR | 0.72814674 |
| 76 | MAP3K14 | 0.72388931 |
| 77 | MST4 | 0.72167035 |
| 78 | ADRBK2 | 0.71351706 |
| 79 | PAK4 | 0.70929247 |
| 80 | ERBB4 | 0.70366802 |
| 81 | TTN | 0.69224743 |
| 82 | MAPKAPK5 | 0.68768300 |
| 83 | IRAK1 | 0.67702386 |
| 84 | MYLK | 0.66698115 |
| 85 | PDGFRA | 0.65739512 |
| 86 | ICK | 0.64700532 |
| 87 | CSNK1G3 | 0.62288801 |
| 88 | TSSK6 | 0.61670291 |
| 89 | CSNK2A1 | 0.61608445 |
| 90 | ARAF | 0.61560361 |
| 91 | MKNK1 | 0.61295713 |
| 92 | PRPF4B | 0.60849443 |
| 93 | MAP4K1 | 0.60466783 |
| 94 | LRRK2 | 0.58898434 |
| 95 | IKBKB | 0.58197510 |
| 96 | CCNB1 | 0.57997763 |
| 97 | LYN | 0.56843715 |
| 98 | RIPK1 | 0.56166336 |
| 99 | ILK | 0.55819056 |
| 100 | MAP2K3 | 0.54125397 |
| 101 | BRSK1 | 0.53360374 |
| 102 | DYRK3 | 0.53293645 |
| 103 | CDC7 | 0.52690140 |
| 104 | AURKA | 0.51691831 |
| 105 | PAK2 | 0.51500833 |
| 106 | RPS6KB2 | 0.51239312 |
| 107 | AURKB | 0.50633540 |
| 108 | JAK3 | 0.49884002 |
| 109 | TAOK2 | 0.49370136 |
| 110 | PRKG2 | 0.49118047 |
| 111 | RPS6KA5 | 0.48782640 |
| 112 | CSNK2A2 | 0.46783708 |
| 113 | ATR | 0.43817050 |
| 114 | PLK1 | 0.43293805 |
| 115 | NLK | 0.43013528 |
| 116 | IKBKE | 0.41794591 |
| 117 | TXK | 0.41446635 |
| 118 | CSNK1A1L | 0.41310704 |
| 119 | EPHB1 | 0.40527412 |
| 120 | WNK4 | 0.39350695 |
| 121 | MAPKAPK2 | 0.38606885 |
| 122 | MAP3K1 | 0.37348245 |
| 123 | MAPK11 | 0.37239686 |
| 124 | CAMK2G | 0.35905107 |
| 125 | CLK1 | 0.35448652 |
| 126 | MATK | 0.34816962 |
| 127 | PRKD2 | 0.34460045 |
| 128 | CDK14 | 0.34148581 |
| 129 | CDK11A | 0.33759697 |
| 130 | RAF1 | 0.33472744 |
| 131 | PAK1 | 0.32842451 |
| 132 | MAP3K8 | 0.32607175 |
| 133 | NUAK1 | 0.32377303 |
| 134 | MKNK2 | 0.32257084 |
| 135 | PIM1 | 0.32069650 |
| 136 | MET | 0.31744906 |
| 137 | MARK3 | 0.30738001 |
| 138 | PRKCI | 0.30402078 |
| 139 | CDK15 | 0.30147038 |
| 140 | BMX | 0.28702247 |
| 141 | CDK18 | 0.27748276 |
| 142 | GSK3A | 0.27356021 |
| 143 | GRK5 | 0.24651913 |
| 144 | PTK6 | 0.22303837 |
| 145 | MAP3K13 | 0.19973544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.15632679 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.37662894 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.19363804 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.68447041 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.67346721 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.34874939 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34355144 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12055900 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.97946808 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.95002546 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.94112420 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.93964160 |
| 13 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.89923655 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.85573737 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.85363398 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71041166 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65247927 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.62734235 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.61892344 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59844894 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59052621 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57742618 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53640106 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.51519794 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.43606425 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42641652 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.42411564 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.40321449 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36202200 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35165430 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34757376 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30096392 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29446687 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27602376 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.24351989 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20451159 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19375490 |
| 38 | Bladder cancer_Homo sapiens_hsa05219 | 1.17597538 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17403159 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16352199 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.14808290 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11049754 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.08471932 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08438324 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08148598 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06794332 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.05970872 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.05788386 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04653977 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03656064 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01459990 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01237948 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00224188 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99595670 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98234903 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96985366 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95976113 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93927731 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89948527 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.89640607 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89518151 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89218026 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87688116 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.86999552 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85689159 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.83527938 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83457798 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81715395 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.81212372 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80838993 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80473035 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79720816 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78188734 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75699474 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75537516 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73804469 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73518923 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.73417668 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72206633 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.71774279 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71551286 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70669619 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70376673 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69889063 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69571812 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69520192 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.69309454 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68399166 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68340307 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67330719 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66708763 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64747637 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64554581 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64182240 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64131032 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62854022 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62694155 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62173172 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61294622 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60791092 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59485994 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58389864 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58323159 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57464615 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57316980 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56603855 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55489297 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55409997 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54613055 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.54521330 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54438565 |
| 112 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54344578 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53508064 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53408175 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53338619 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51649787 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51510405 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51023896 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50473449 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49618955 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49539135 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48872954 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48569363 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47791570 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47054273 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46575008 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45866651 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45618620 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45202331 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.45088659 |
| 131 | RNA degradation_Homo sapiens_hsa03018 | 0.44981024 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44433028 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44178524 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41539779 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.41502843 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39781686 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38885393 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38489083 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38272305 |

